![Christine Esau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Christine Esau is currently the Vice President-Research & Development at Arcturus Therapeutics Ltd.
and the Chief Financial Officer at 1Strand.
She holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the California Institute of Technology.
Postes actifs de Christine Esau
Sociétés | Poste | Début |
---|---|---|
Arcturus Therapeutics Ltd.
![]() Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2015 |
Formation de Christine Esau
California Institute of Technology | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Arcturus Therapeutics Ltd.
![]() Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |